Access cutting-edge hidradenitis suppurativa (hs) treatment through this clinical trial at a research site in Rosemead. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Rosemead location
Preparing your pre-screening questions…
Access hidradenitis suppurativa (hs) specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related hidradenitis suppurativa (hs) treatment provided free
Check if you qualify for this hidradenitis suppurativa (hs) clinical trial in Rosemead, CA
No-Cost Study Care
Local to Rosemead
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Hidradenitis suppurativa (HS) is a long-lasting skin condition that causes painful lumps, abscesses, and tunnels in areas such as the armpits and groin. HS begins around the hair follicle; when the follicle becomes blocked and inflamed, new lesions form. Prior clinical studies of lasers that act on the hair follicle have shown improvement in HS symptoms, and a 1726-nm diode laser-designed to selectively heat oil glands within the follicle-has reduced inflammatory lesions in acne with good tolerability across many skin types. This study will test whether a 1726-nm diode laser can safely reduce inflammatory HS lesions in Hurley stage I-II disease. Adults with bilateral (right/left) affected areas will be randomized so that one side receives active laser treatment and the other side receives a sham procedure. Participants will have three treatment sessions over 8 weeks and follow-up through Week 24 while continuing their stable HS medications. The primary outcome is the percent change in abscess and inflammatory nodule counts on the treated side versus the sham side at Week 16. Secondary outcomes include validated HS responder scores, pain, quality of life, flare rate/antibiotic use, and safety. Results may support a non-ablative, follicle-directed option for early HS.
Sponsor: Wynn Medical Center
Yes, this clinical trial (NCT07155239) has an active research site in Rosemead, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for hidradenitis suppurativa (hs) treatment options in Rosemead, CA, this clinical trial (NCT07155239) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Rosemead research site is actively enrolling participants for this clinical trial. You'll receive care from experienced hidradenitis suppurativa (hs) specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all hidradenitis suppurativa (hs) clinical trials near you to find additional studies recruiting in your area.
See all alzheimers disease clinical trials recruiting in Rosemead — not just this study.
Browse Alzheimers Disease Trials in Rosemead →